Shaker Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-6,791
| Closed | -$1.4M | – | 95 |
|
2024
Q2 | $1.4M | Sell |
6,791
-25
| -0.4% | -$5.17K | 0.61% | 54 |
|
2024
Q1 | $1.85M | Buy |
6,816
+33
| +0.5% | +$8.94K | 0.78% | 51 |
|
2023
Q4 | $1.6M | Sell |
6,783
-1,119
| -14% | -$265K | 0.75% | 51 |
|
2023
Q3 | $1.55M | Sell |
7,902
-46
| -0.6% | -$9.02K | 0.85% | 45 |
|
2023
Q2 | $1.67M | Sell |
7,948
-2,014
| -20% | -$423K | 0.85% | 44 |
|
2023
Q1 | $2.01M | Buy |
9,962
+96
| +1% | +$19.4K | 1.12% | 31 |
|
2022
Q4 | $2.15M | Buy |
9,866
+7,534
| +323% | +$1.64M | 1.33% | 27 |
|
2022
Q3 | $459K | Buy |
2,332
+8
| +0.3% | +$1.58K | 0.31% | 68 |
|
2022
Q2 | $497K | Buy |
2,324
+3
| +0.1% | +$642 | 0.32% | 75 |
|
2022
Q1 | $659K | Sell |
2,321
-1,833
| -44% | -$520K | 0.34% | 72 |
|
2021
Q4 | $1.57M | Sell |
4,154
-946
| -19% | -$356K | 0.67% | 41 |
|
2021
Q3 | $2.11M | Buy |
5,100
+33
| +0.7% | +$13.6K | 0.93% | 33 |
|
2021
Q2 | $1.87M | Buy |
5,067
+7
| +0.1% | +$2.59K | 0.87% | 37 |
|
2021
Q1 | $1.47M | Sell |
5,060
-435
| -8% | -$126K | 0.71% | 48 |
|
2020
Q4 | $1.37M | Buy |
5,495
+65
| +1% | +$16.2K | 0.69% | 46 |
|
2020
Q3 | $1.23M | Hold |
5,430
| – | – | 0.63% | 51 |
|
2020
Q2 | $947K | Hold |
5,430
| – | – | 0.54% | 46 |
|
2020
Q1 | $685K | Buy |
5,430
+195
| +4% | +$24.6K | 0.59% | 44 |
|
2019
Q4 | $800K | Hold |
5,235
| – | – | 0.48% | 51 |
|
2019
Q3 | $693K | Hold |
5,235
| – | – | 0.45% | 54 |
|
2019
Q2 | $743K | Buy |
5,235
+35
| +0.7% | +$4.97K | 0.49% | 49 |
|
2019
Q1 | $755K | Hold |
5,200
| – | – | 0.52% | 49 |
|
2018
Q4 | $588K | Hold |
5,200
| – | – | 0.51% | 43 |
|
2018
Q3 | $700K | Hold |
5,200
| – | – | 0.43% | 49 |
|
2018
Q2 | $584K | Sell |
5,200
-2,840
| -35% | -$319K | 0.36% | 55 |
|
2018
Q1 | $858K | Hold |
8,040
| – | – | 0.53% | 46 |
|
2017
Q4 | $880K | Hold |
8,040
| – | – | 0.58% | 39 |
|
2017
Q3 | $868K | Buy |
8,040
+1,640
| +26% | +$177K | 0.6% | 41 |
|
2017
Q2 | $647K | Buy |
+6,400
| New | +$647K | 0.49% | 50 |
|